Raphaël Saffroy

2.8k citations
79 papers · 1.8k indexed · h-index 27

Raphaël Saffroy

70 papers receiving 1.7k citations

Peers

Raphaël Saffroy
Comparison fields: 5 of 102
  • Hepatology 243
  • Genetics 239
  • Cancer Research 288
  • Oncology 491
  • Hematology 168
Replace Fan Lin with:
Fan Lin United States
Martin Volkmann Germany
Kaı̈ss Lassoued France
Tadao Manabe Japan
Yasuo Hirono Japan
Changping Wu China
Dominik Rüttinger Germany
Margret Rave‐Fränk Germany
Eun Kyung Hong South Korea
Raphaël Saffroy relative to Fan Lin United States Fan Lin's profile →
Citations per field
00.5×2.7×
Fan Lin · 1×
Citations per year

Countries citing papers authored by Raphaël Saffroy

Since Specialization
Citations

This map shows the geographic impact of Raphaël Saffroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphaël Saffroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphaël Saffroy more than expected).

Fields of papers citing papers by Raphaël Saffroy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphaël Saffroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphaël Saffroy. The network helps show where Raphaël Saffroy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raphaël Saffroy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphaël Saffroy Line = papers co-authored together Raphaël Saffroy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202028
3 201923
4 20194
5 20181
6 201634
7 20160
8 201574
9 20144
10 201052
11 201042
12 200912
13 200911
14 200810
15 200612
16 200532
17
Biologie moléculaire et carcinome hépatocellulaire : données actuelles et développements futurs
20048
18 200448
19 200316
20 20026

About Raphaël Saffroy

Raphaël Saffroy is a scholar working on Genetics, Hepatology and Cancer Research, having authored 79 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer-related Molecular Pathways (7 papers), Lung Cancer Treatments and Mutations (7 papers), Folate and B Vitamins Research (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Hepatology (243 citations), Genetics (239 citations) and Cancer Research (288 citations). Raphaël Saffroy has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Antoinette Lemoine, Brigitte Debuire, Daniel Azoulay, Patrick Pham, Mylène Sebagh, J. HAMELIN, Francine Rendu, Christilla Bachelot‐Loza, Nelly Bosselut and Pasquale F. Innominato. Their work appears in journals such as Oncotarget, Acta Neuropathologica Communications, Brain Pathology, British Journal of Cancer and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026